scorecard
  1. Home
  2. business
  3. startups
  4. news
  5. Health edtech platform Virohan raises $7 million in funding led by Blume Ventures

Health edtech platform Virohan raises $7 million in funding led by Blume Ventures

Health edtech platform Virohan raises $7 million in funding led by Blume Ventures
  • With this fundraise, Virohan is aiming to expand to over 200 new campuses across India, training over 7000 students. The funds will also be used to launch new training programs, scale omnichannel training platform infrastructure and include content in vernacular languages.
  • The health edtech platform has raised a total capital of $11 million till date.
  • Virohan trains students to become allied healthcare professionals – India faces an acute shortage of these professionals, with an existing gap of 5 million workers and an estimated gap of 35 million by 2028.
  • Gurgaon-based Virohan was founded in 2018 by Kunaal Dudeja, Nalin Saluja and Archit Jayaswal.
Healthcare edtech startup Virohan has raised $7 million in a pre-Series B1 round led by Blume Ventures with participation from Bharat Inclusion Seed Fund, Rebright Partners and Lesing Artha Limited.

This also includes $500K from Harshvardhan Rajgarhia, as part of Lets Venture, ALES Japan, Shantanu Jain (Managing Director, JP Morgan Chase – Singapore), Deepa Bagla Financial Consultants and others. This latest round of funding takes the company’s total capital raised till date to $11 million.

With this fundraise, Virohan is aiming to expand to over 200 new campuses across India, training over 7000 students. The company also plans to use the funds to develop and launch new training programs, scale its omnichannel training platform infrastructure and content in vernacular languages along with developing new features to further increase learning outcomes for students. It also aims to tap into Japanese markets with the support from its existing investors ALES and Rebright Partners.

“The severe shortage in healthcare workers came to the fore during the pandemic but continues to remain a persistent problem for several decades now. Virohan's offering, sitting at the intersection of healthcare and education, is working well to solve this problem,” Ashwin Raguraman, co-founder and partner, Bharat Fund said.

Started in 2018, Virohan is a healthcare edtech platform that trains students in allied healthcare programs (AHP). Allied healthcare professionals are technicians in the healthcare industry who form 60% of the healthcare workforce and include technicians like phlebotomists, medical lab technicians, operating theatre technicians, etc.

India faces an acute shortage of AHP technicians with an existing gap of 5 million workers and an estimated gap of 35 million by 2028, the company said in a statement.

“Virohan’s vision has always been to train AHPs keeping industry demand and requirement at the forefront. In the next 18 months Virohan will deepen its relationship with its stakeholders (students, universities/colleges & medical institutions), train over 10,000 students, and establish an international presence to cater to over $100 billion global opportunity,” said Kunaal Dudeja, co-founder and CEO of Virohan.

The Gurgaon-based startup was founded by Dudeja, Nalin Saluja and Archit Jayaswal who have backgrounds in retail, sales, technology, product development and finance.

Virohan said it has trained over 7000 students through its courses which has seen over 96% completion rates and over 98% placement rates within one month of program completion. It assists Fortis Escorts, 1MG, Dr. Lal Path Labs, Sarvodaya Healthcare, Healthians, etc to help students get internships and job offers.

“Education can also help leapfrog social classes and economic cohorts. Hence, we have consistently bet on education startups lowering barriers for access and expanding opportunities to all. This is why we are excited to partner with Virohan, for its ambition and mission to skill and upgrade the next hundred million Indians,” Sajith Pai, director , Blume Ventures said.

SEE ALSO: Indian generic drug Paxlovid in high demand in China amid Covid surge
Kashmiri poet and Jnanpith awardee Rehman Rahi passes away at 98

READ MORE ARTICLES ON



Popular Right Now



Advertisement